ClinicalThought

Share

Program Content

Activities

  • httpPROTAC ER Degraders in ER+/HER2- MBC
    PROTAC ER Degraders in ER+/HER2- MBC Progressing After Endocrine Therapy: Emerging Mechanisms and Implications for Clinical Practice on the Horizon
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 21, 2025

    Expires: January 20, 2026

Faculty

cover img faculity

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Chair, Breast Executive Committee
Sarah Cannon Research Institute
Nashville, Tennessee

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.